Mounjaro is a once-weekly injectable medication developed by Eli Lilly. Its active ingredient, tirzepatide, helps control blood sugar and reduce appetite by targeting two hormone receptors involved in metabolism (GIP and GLP-1).
It is primarily prescribed for:
Type 2 Diabetes management
Weight loss and obesity treatment (in many countries under medical guidance)
Common benefits:
Better blood sugar control
Reduced hunger and cravings
Significant weight reduction in many patients
Common side effects:
Nausea
Vomiting
Diarrhea or constipation
Reduced appetite
It should only be used under a doctor’s supervision, especially for people with diabetes, digestive issues, or thyroid-related conditions.
